ACCESSION: MSBNK-SMB_Measured-HSA015P0153004
RECORD_TITLE: Uncharacterized; LC-ESI-QFT; MS2; POSITIVE; Averaged data
DATE: 2025.04.02 (Averaged 2025.02.21, Processed 2025.02.21, Annotated 2025.03.31, Curated 2025.04.02)
AUTHORS: Shin-MassBank project
LICENSE: CC BY-NC-SA
PUBLICATION: Ruggiero et al. Int J Cancer. 2023, 153, 1, 210-223
COMMENT: This is an averaged mass spectra data created by averaging product ion scan data obtained from the following DDA dataset.
COMMENT: REPOSITORY MetaboLights
COMMENT: DATASET_ID MTBLS6402
COMMENT: DATASET_TITLE FSCN1 as a new druggable target in adrenocortical carcinoma
COMMENT: DATASET_AUTHORS Andrei Turtoi, Enzo Lalli
COMMENT: MS1_M/Z_AVERAGED_THRES 5.000
COMMENT: MS2_M/Z_AVERAGED_THRES 5.000
COMMENT: DATASET_FILE_NUM 27
COMMENT: NUM_AVERAGED_SPEC 20
COMMENT: RAW_SPEC {'EL22_pos_3952': {'bp': 380399.0, 'sum': 2170287.0}, 'EL02_pos_3347': {'bp': 372978.0, 'sum': 1694013.0}, 'EL06_pos_3334': {'bp': 334016.0, 'sum': 1500515.0}, 'EL05_pos_3347': {'bp': 330034.0, 'sum': 1513229.0}, 'EL18_pos_3921': {'bp': 329851.0, 'sum': 1708554.0}, 'EL21_pos_3921': {'bp': 325394.0, 'sum': 1806898.0}, 'EL10_pos_3334': {'bp': 324224.0, 'sum': 1308201.0}, 'EL19_pos_3940': {'bp': 323903.0, 'sum': 1845758.0}, 'EL09_pos_3335': {'bp': 322062.0, 'sum': 1399938.0}, 'EL17_pos_3917': {'bp': 320038.0, 'sum': 1743645.0}, 'EL24_pos_3357': {'bp': 317581.0, 'sum': 1298311.0}, 'EL11_pos_3333': {'bp': 309691.0, 'sum': 1335441.0}, 'EL07_pos_3327': {'bp': 308803.0, 'sum': 1353636.0}, 'EL20_pos_3917': {'bp': 306409.0, 'sum': 1732049.0}, 'EL23_pos_3351': {'bp': 305600.0, 'sum': 1287517.0}, 'EL04_pos_3339': {'bp': 303454.0, 'sum': 1253135.0}, 'EL01_pos_3334': {'bp': 298159.0, 'sum': 1393542.0}, 'EL16_pos_3916': {'bp': 297909.0, 'sum': 1644607.0}, 'EL08_pos_3333': {'bp': 295522.0, 'sum': 1209900.0}, 'EL15_pos_3935': {'bp': 292305.0, 'sum': 1526029.0}}
COMMENT: RETENTION_TIME_STDEV 0.478
COMMENT: PRECURSOR_M/Z_RAW 153.138804
COMMENT: PRECURSOR_M/Z_STDEV 0.000039
COMMENT: PRECURSOR_IN_MS1 mz 153.138641; int 64.200; delta(ppm) 0.952173
COMMENT: PROPOSED_CHARGE_STATE ND
COMMENT: PROPOSED_ISOTOPE_STATE ND
COMMENT: PROPOSED_MAX_NUM_S 0
COMMENT: PROPOSED_MF SevenGoldenRules 0.112; C9H16N2; [M+H]+; delta(ppm) 0.111746
COMMENT: PROPOSED_MF MS-FINDER 2.947; C9H16N2; [M+H]+; delta(ppm) 0.111291
COMMENT: PROPOSED_MF SIRIUS5_Sirius 10.044; C9H16N2; [M+H]+; delta(ppm) 0.111291
COMMENT: PROPOSED_MF SIRIUS5_Zodiac 1.000; C9H16N2; [M+H]+; delta(ppm) 0.111291
COMMENT: PROPOSED_MF SIRIUS6_Sirius 13.465; C9H16N2; [M+H]+; delta(ppm) 0.111291
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 1.000; C9H16N2; [M+H]+; delta(ppm) 0.111291
COMMENT: PROPOSED_COMPOUND SIMILARITY:GNPS 3.000; GQHTUMJGOHRCHB-UHFFFAOYSA-N; C9H16N2; Spectral Match to Pyrimido[1,2-a]azepine, 2,3,4,6,7,8,9,10-octahydro- from NIST14
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.407; GQHTUMJGOHRCHB-UHFFFAOYSA-N; [M+H]+; C1CN=C2CCCCCN2C1
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.231; ZAMSZEJXPKRPMU-UHFFFAOYSA-N; [M+H]+; N(=CC1=C(N)CCC(C)C1)C
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.154; WYVKQPSDGDWDEF-UHFFFAOYSA-N; [M+H]+; N1=C(C=C(N1C(C)(C)C)C)C
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.681; GQHTUMJGOHRCHB-UHFFFAOYSA-N; [M+H]+; 1,8-diazabicyclo[5.4.0]undec-7-ene
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.666; WYVKQPSDGDWDEF-UHFFFAOYSA-N; [M+H]+; 1-tert-butyl-3,5-dimethyl-1H-pyrazole
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.562; ZAMSZEJXPKRPMU-UHFFFAOYSA-N; [M+H]+; 4-methyl-2-[(methylimino)methyl]cyclohex-1-en-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; ZAMSZEJXPKRPMU-UHFFFAOYSA-N; [M+H]+; 4-methyl-2-[(methylimino)methyl]cyclohex-1-en-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.608; GQHTUMJGOHRCHB-UHFFFAOYSA-N; [M+H]+; 1,8-diazabicyclo[5.4.0]undec-7-ene
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.536; WYVKQPSDGDWDEF-UHFFFAOYSA-N; [M+H]+; 1-tert-butyl-3,5-dimethyl-1H-pyrazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 3.601; GQHTUMJGOHRCHB-UHFFFAOYSA-N; [M+H]+; 2,3,4,6,7,8,9,10-octahydropyrimido[1,2-a]azepine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.333; PPVWIPXCUJDBCZ-UHFFFAOYSA-N; [M+H]+; 2-(tert-butylamino)-3-methylbut-2-enenitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.288; CVROVTGNNDIZNS-UHFFFAOYSA-N; [M+H]+; 4-piperidin-1-ylbutanenitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.268; GDQLRKPUJAWNNP-UHFFFAOYSA-N; [M+H]+; 3-(azepan-1-yl)propanenitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.250; SDHHZJUUIBWPPN-UHFFFAOYSA-N; [M+H]+; 1-(dimethylamino)cyclohexane-1-carbonitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.250; FVHNIWSSACDLBF-UHFFFAOYSA-N; [M+H]+; 1-(ethylamino)cyclohexane-1-carbonitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.226; YXKJVSMPXUNZLK-UHFFFAOYSA-N; [M+H]+; 1-(2-methylpropyl)pyrrolidine-3-carbonitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.208; KJERDGDGTPYXIV-UHFFFAOYSA-N; [M+H]+; 4-propan-2-ylpiperidine-4-carbonitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.171; JKVSQMWIMFRPCJ-UHFFFAOYSA-N; [M+H]+; N-[(1-methylpyrrol-2-yl)methyl]propan-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.148; CMGFSOAWZMKIEI-UHFFFAOYSA-N; [M+H]+; 3-(2,4-dimethylpyrrol-1-yl)propan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.069; KGWVFQAPOGAVRF-UHFFFAOYSA-N; [M+H]+; 1-hexylimidazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.934; SJFHISLGBSSBQE-UHFFFAOYSA-N; [M+H]+; 3-(2-methylpiperidin-1-yl)propanenitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.918; OLUJYRYCQHJDKJ-UHFFFAOYSA-N; [M+H]+; 3-(cyclohexylamino)propanenitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.911; GZBWIJDICIGGKJ-UHFFFAOYSA-N; [M+H]+; 1-but-3-ynyl-4-methylpiperazine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.895; FXDOBDLENLQBBY-HRDYMLBCSA-N; [M+H]+; (1S,7S,8R)-2,5-diazatricyclo[6.2.1.02,7]undecane
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.835; KCDHDSZBVKYFRC-CBAPKCEASA-N; [M+H]+; (1S,4S)-2-cyclobutyl-2,5-diazabicyclo[2.2.1]heptane
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.829; ZDQIJSBTWINFST-UHFFFAOYSA-N; [M+H]+; (2-cyclopropyl-2-azabicyclo[2.1.1]hexan-1-yl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.792; WUFZNKYXOCYWQI-UHFFFAOYSA-N; [M+H]+; 1-but-3-ynylpiperidin-4-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.792; JXONRTFVGJURQF-UHFFFAOYSA-N; [M+H]+; N,N-dimethyl-1-prop-2-ynylpyrrolidin-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.777; PJSJVTZSFIRYIZ-UHFFFAOYSA-N; [M+H]+; 3,5-di(propan-2-yl)-1H-pyrazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.758; JVDTWAMFTGWSKS-UHFFFAOYSA-N; [M+H]+; 4-(2,5-dihydropyrrol-1-yl)piperidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.750; YYFQXGFCHVDBPR-UHFFFAOYSA-N; [M+H]+; 3-(4,5-dimethyl-1H-pyrrol-3-yl)propan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.738; CZCCYJJBCQXQTM-UHFFFAOYSA-N; [M+H]+; 2-methyl-2-piperidin-4-ylpropanenitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.367; VZTHTEUIDBTOLX-UHFFFAOYSA-N; [M+H]+; 5-pyrrolidin-1-ylpentanenitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.333; UQHYVHRBGYMGHE-UHFFFAOYSA-N; [M+H]+; 1-(2-methylbut-3-yn-2-yl)piperazine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.333; FVGWKOUTWIUQRL-UHFFFAOYSA-N; [M+H]+; 1-(1-bicyclo[1.1.1]pentanyl)piperazine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -96.628; GDQLRKPUJAWNNP; [M+H]+; 3-(azepan-1-yl)propanenitrile
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -100.204; CVROVTGNNDIZNS; [M+H]+; 4-piperidylbutanenitrile
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -101.552; VZTHTEUIDBTOLX; [M+H]+; 1-Pyrrolidinevaleronitrile
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -110.761; HTWWMEWXLRWYHS; [M+H]+; Hexahydro-2H-azocine-1-acetonitrile
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -125.741; SJFHISLGBSSBQE; [M+H]+; 1-(2-Cyanoethyl)-2-pipecoline
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -130.164; OLUJYRYCQHJDKJ; [M+H]+; N-(2-Cyanoethyl)cyclohexylamine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -140.805; FVHNIWSSACDLBF; [M+H]+; 1-(Ethylamino)cyclohexanecarbonitrile
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -141.859; PATGXOSMIGXGKT; [M+H]+; 2-Butyl-5,6-dihydro-3-methylpyrazine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -155.927; GQHTUMJGOHRCHB; [M+H]+; polycat dbu
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -161.342; SDHHZJUUIBWPPN; [M+H]+; 1-(Dimethylamino)cyclohexanecarbonitrile
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -168.833; CMGFSOAWZMKIEI; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -175.422; KGWVFQAPOGAVRF; [M+H]+; 1-Hexylimidazole
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -210.736; ZAMSZEJXPKRPMU; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -240.428; PJSJVTZSFIRYIZ; [M+H]+; 3,5-Diisopropylpyrazole
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -274.616; WYVKQPSDGDWDEF; [M+H]+; 1-tert-butyl-3,5-dimethylpyrazole
COMMENT: PROPOSED_COMPOUND SIRIUS5_Confidence:biodatabase 0.201; GDQLRKPUJAWNNP; [M+H]+; 3-(azepan-1-yl)propanenitrile
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -165.621; HTWWMEWXLRWYHS; [M+H]+; Hexahydro-2H-azocine-1-acetonitrile
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -170.211; GZBWIJDICIGGKJ; [M+H]+; 1-But-3-ynyl-2,2,6,6-tetradeuterio-4-methylpiperazine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -173.034; CVROVTGNNDIZNS; [M+H]+; 4-Piperidin-1-ium-1-ylbutanenitrile
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -177.634; OLUJYRYCQHJDKJ; [M+H]+; 2-Cyanoethyl(cyclohexyl)azanium
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -181.979; GDQLRKPUJAWNNP; [M+H]+; 3-(Azepan-1-yl)propanenitrile
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -182.439; VZTHTEUIDBTOLX; [M+H]+; Pyrrolidine-1-valeronitrile
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -187.786; SDHHZJUUIBWPPN; [M+H]+; 1-(Dimethylamino)cyclohexanecarbonitrile
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -187.796; FVHNIWSSACDLBF; [M+H]+; 1-(Ethylamino)cyclohexanecarbonitrile
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -200.768; PATGXOSMIGXGKT; [M+H]+; 2-Butyl-5,6-dihydro-3-methylpyrazine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -217.261; XUAXVBUVQVRIIQ; [M+H]+; 1-Butyl-3-methyl-2-(trideuteriomethyl)imidazol-3-ium
COMMENT: PROPOSED_COMPOUND SIRIUS6_Confidence:biodatabase 0.052; HTWWMEWXLRWYHS; [M+H]+; Hexahydro-2H-azocine-1-acetonitrile
COMMENT: CONFIDENCE Level 4: Unequivocal precursor ion formula C9H17N2; Top hit by both SIRIUS6_Zodiac and MS-FINDER; and SevenGoldenRules(1), SIRIUS5_Sirius(1), SIRIUS5_Zodiac(1);
CH$COMPOUND_CLASS: Uncharacterized
CH$FORMULA: C39H42O2
CH$EXACT_MASS: 542.318480
CH$SMILES: CCCC#Cc1cc(C#CCCC)cc(C#Cc2cc(C#CC(C)(C)C)c(cc2C#CC(C)(C)C)C2OCCO2)c1
CH$IUPAC: InChI=1S/C39H42O2/c1-9-11-13-15-30-25-31(16-14-12-10-2)27-32(26-30)17-18-33-28-35(20-22-39(6,7)8)36(37-40-23-24-41-37)29-34(33)19-21-38(3,4)5/h25-29,37H,9-12,23-24H2,1-8H3
CH$LINK: PUBCHEM CID:11353257
SP$SCIENTIFIC_NAME: Homo sapiens
SP$LINK: NCBI-TAXONOMY 9606 
SP$SAMPLE: Cell
AC$INSTRUMENT: Vanquish Flex UHPLC system, Thermo Fisher Scientific - Orbitrap Q Exactive Plus mass spectrometer, Thermo Fisher Scientific
AC$INSTRUMENT_TYPE: LC-ESI-QFT
AC$MASS_SPECTROMETRY: MS_TYPE MS2
AC$MASS_SPECTROMETRY: ION_MODE POSITIVE
AC$MASS_SPECTROMETRY: COLLISION_ENERGY Ramped collision energies of 40 V
AC$MASS_SPECTROMETRY: FRAGMENTATION_MODE CID
AC$MASS_SPECTROMETRY: ION_SPRAY_VOLTAGE 4.0 kV
AC$MASS_SPECTROMETRY: IONIZATION ESI
AC$MASS_SPECTROMETRY: MASS_ACCURACY MS1(ppm) 5.00; MS2(ppm) 5.00
AC$CHROMATOGRAPHY: COLUMN_NAME ZORBAX Pursuit 3 PFP (3 Âµm, 2.0 mm x 150 mm; Agilent Technologies)
AC$CHROMATOGRAPHY: FLOW_GRADIENT The gradient profile was linear decrease from 0-25% B from 0-2 min; fast linear increase from 25-35% B from 2-11 min; 95% B hold from 15-20 min;fast linear decrease from 95-0% B from 20-21 min. 
AC$CHROMATOGRAPHY: RETENTION_TIME 5.788
MS$FOCUSED_ION: PRECURSOR_M/Z 153.138642
MS$DATA_PROCESSING: RECALIBRATE Data dependent recalibration using whole DDA dataset
PK$SPLASH: splash10-0f89-2900000000-c7aeaad7cd883c99a0e0
PK$ANNOTATION: m/z int m/z_nocal m/z_std(ppm) int_std cor n annotation
  65.0387918 119.3239 65.039531 1.0917 110.04 0.5929 15 f{C5H5}/3.31ppm,p-C4H12N2
  70.9419038 44.7260 70.942647 0.8035 5.71 0.4256 20 ?
  71.9404200 23.9863 71.941163 1.1398 5.76 0.5172 17 ?
  72.9372376 377.1830 72.937980 0.2468 40.70 0.4947 20 ?
  78.9498635 12.2301 78.950596 1.3680 3.15 -0.0571 20 ?
  79.0543218 29.7495 79.055054 0.9867 13.36 -0.2662 20 f{C6H7}/1.20ppm,p-C3H10N2
  79.9490343 11.2542 79.949764 1.1507 2.60 0.2941 17 ?
  80.9451122 111.2296 80.945839 0.3830 8.11 0.1850 20 ?
  81.0699658 18.8067 81.070692 1.0978 5.83 0.0258 18 f{C6H9}/1.10ppm,p-C3H8N2
  83.0604545 48.8385 83.061174 0.9030 26.98 0.7368 20 f{C4H7N2}/0.96ppm,p-C5H10
  90.9477086 59.0794 90.948389 0.9236 6.94 0.3654 20 ?
  93.0700173 18.1757 93.070684 0.9885 3.75 -0.2947 20 f{C7H9}/1.51ppm,p-C2H8N2
  95.0492708 11.3390 95.049924 1.4624 3.29 0.4241 20 ?
  95.0855823 11.8824 95.086235 1.3567 3.47 -0.0441 17 f{C7H11}/0.58ppm,p-C2H6N2
  96.0682115 93.0892 96.068856 0.6350 16.84 0.4541 20 f{C5H8N2}/0.12ppm,p-C4H9
  98.9555699 59.8153 98.956192 0.8388 6.03 0.3023 20 ?
  107.0855927 25.4531 107.086135 1.5035 8.07 -0.2074 18 f{C8H11}/0.62ppm,p-C1H6N2
  109.0649011 9.4981 109.065430 1.3203 1.91 0.1265 16 ?
  109.1012869 15.9061 109.101816 1.0449 3.56 0.2511 20 f{C8H13}/1.01ppm,p-C1H4N2
  111.0441610 164.7559 111.044676 0.7114 161.17 0.7059 16 ?
  111.0804763 9.6820 111.080991 1.4224 3.20 0.1324 16 ?
  111.9683160 32.0517 111.968824 1.5808 5.76 0.5667 19 ?
  113.9637080 285.4581 113.964200 0.3422 23.53 0.5038 20 ?
  114.9708515 28.6116 114.971335 1.3395 5.73 -0.2965 19 ?
  115.9700731 23.4337 115.970549 1.2158 4.23 0.5263 20 ?
  116.9662027 253.3769 116.966669 0.3762 15.23 0.3519 20 ?
  125.0597153 87.9946 125.060104 1.4313 91.65 0.6305 18 ?
  125.0961833 13.7235 125.096572 1.2790 3.54 0.3179 15 ?
  128.9865047 100.1565 128.986851 0.6125 7.03 0.1233 20 ?
  129.9859671 82.9747 129.986302 0.8924 7.68 -0.0571 20 ?
  130.9818832 999.0000 130.982206 0.2672 7.14 0.4361 20 ?
  131.9740480 82.8221 131.974359 1.2654 10.85 0.2767 20 ?
  131.9824316 23.6521 131.982743 0.6137 3.80 0.1534 20 ?
  139.9821587 25.6233 139.982433 1.4788 4.31 0.0140 19 ?
  152.0026551 13.4933 152.002961 1.2368 2.40 -0.0643 15 ?
  152.0705501 13.3605 152.070856 1.5519 4.25 -0.1471 17 ?
  152.1070014 20.0791 152.107308 1.4661 6.22 0.7281 19 ?
  153.0908278 17.4310 153.091137 1.0321 3.89 0.0857 20 ?
  153.1386137 719.7049 153.138923 0.2808 118.28 1.0000 20 f{C9H17N2}/-0.07ppm,p
  153.9977688 133.8767 153.998080 0.4286 7.17 0.5714 20 ?
  154.1422832 84.3828 154.142595 0.8953 16.50 0.8333 19 ?
PK$NUM_PEAK: 41
PK$PEAK: m/z int. rel.int.
  65.038792 119.32 119
  70.941904 44.73 44
  71.940420 23.99 23
  72.937238 377.18 377
  78.949864 12.23 12
  79.054322 29.75 29
  79.949034 11.25 11
  80.945112 111.23 111
  81.069966 18.81 18
  83.060455 48.84 48
  90.947709 59.08 59
  93.070017 18.18 18
  95.049271 11.34 11
  95.085582 11.88 11
  96.068211 93.09 93
  98.955570 59.82 59
  107.085593 25.45 25
  109.064901 9.50 9
  109.101287 15.91 15
  111.044161 164.76 164
  111.080476 9.68 9
  111.968316 32.05 32
  113.963708 285.46 285
  114.970852 28.61 28
  115.970073 23.43 23
  116.966203 253.38 253
  125.059715 87.99 87
  125.096183 13.72 13
  128.986505 100.16 100
  129.985967 82.97 82
  130.981883 999.00 999
  131.974048 82.82 82
  131.982432 23.65 23
  139.982159 25.62 25
  152.002655 13.49 13
  152.070550 13.36 13
  152.107001 20.08 20
  153.090828 17.43 17
  153.138614 719.70 719
  153.997769 133.88 133
  154.142283 84.38 84
//
